latest news releases from the newsroom
ACI Worldwide, Inc.
ACI and Infoglide Software Provide Powerful Retail Returns Fraud Solution
NEW YORK, March 3, 2008 (PRIME NEWSWIRE) -- ACI Worldwide (Nasdaq:ACIW), a leading international provider of software for electronic payment systems, today announced a partnership with Infoglide Software Corporation, a provider of identity resolution and analysis software, to offer enhanced returns authorization and employee screening solutions for the retail industry. The companies have combined resources to provide enhancements around returns authorization, loss prevention intelligence, employee risk screening and "eFencing" intelligence.
Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. to Present At the Susquehanna Financial Healthcare Conference
NORTHVALE, N.J., March 3, 2008 (PRIME NEWSWIRE) -- Elite Pharmaceuticals, Inc. (AMEX:ELI), a leading drug delivery, specialty pharmaceutical company focused primarily on developing and commercializing proprietary abuse resistant, extended release pain compounds, today announced that Chris Dick, Executive Vice President of Corporate Development, will be presenting at Susquehanna Financial Group's "SIGnificant Options in Healthcare" conference held at the W Hotel, 541 Lexington Avenue at 49th Street in New York City. Mr. Dick's presentation is scheduled to begin at 3:00 p.m. Eastern Standard Time on Wednesday, March 5, 2008.
Innospec Authorizes Additional Share Repurchases
NEWARK, Del., March 3, 2008 (PRIME NEWSWIRE) -- Innospec Inc. (Nasdaq:IOSP) today announced that its Board of Directors has authorized a further Rule 10b5-1 share repurchase plan. Under the new plan, which commences today, the corporation may repurchase shares of common stock up to a total value of $8 million.
Eurand CEO Gearoid Faherty Recognized by the Boomer Esiason Foundation
MILAN, Italy, March 3, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that Gearoid Faherty, Chief Executive Officer, has been recognized by the Boomer Esiason Foundation (BEF) as a "Quiet Giant" for his efforts supporting the U.S. cystic fibrosis (CF) community in 2007. Mr. Faherty will be honored at the 15th Annual Booming Celebration on Saturday March 8, 2008 at The Waldorf -Astoria Hotel, in New York City.